Adcirca vs. Cialis: One Ingredient, Different Treatment Plans
Adcirca and Cialis both contain tadalafil, but clinicians prescribe them for different conditions. Cialis treats ED and symptoms of benign prostatic hyperplasia. Adcirca treats pulmonary arterial hypertension under specialist care. The shared ingredient does not authorize switching products or combining doses independently.
Check the indication. A PAH dose can exceed the standard ED dose because the treatment goal, evidence, and prescribing plan differ. Taking both products can duplicate tadalafil exposure even though the boxes carry separate brand names.
What pulmonary arterial hypertension involves
PAH affects the arteries carrying blood through the lungs. Increased resistance in that circulation makes the heart work harder to move blood forward. Symptoms can include breathlessness, reduced exercise capacity, fatigue, chest discomfort, and fainting.
Adcirca inhibits PDE5 in tissues including the pulmonary blood vessels. By supporting the signaling involved in smooth-muscle relaxation, tadalafil can reduce resistance and improve exercise ability in appropriate patients. A specialist decides how it fits alongside other PAH treatments.
PAH differs from ordinary systemic hypertension measured with an arm cuff. Do not substitute an ED prescription for blood-pressure treatment or assume that a tadalafil tablet treats every condition described as hypertension.
Adcirca can treat suitable male and female patients with PAH. Cialis's ED indication concerns men, while its BPH indication concerns the prostate. The disease and patient assessment determine the product's role.
What Cialis treats
Cialis first received U.S. approval for ED in 2003, and BPH treatment followed later. It helps erectile blood flow during arousal and can improve selected urinary symptoms associated with prostate enlargement.
For ED, tadalafil does not create desire or cause an automatic erection. The patient still needs sexual stimulation. For urinary symptoms, the clinician should consider other causes before assuming BPH explains frequency, urgency, or a weak stream.
The available strengths and schedules let clinicians use Cialis daily or as needed for ED. Daily BPH treatment follows a different purpose from an occasional tablet before sex, even when a 5 mg tablet appears in both discussions.
How doses compare
| Product and use | Common adult regimen | Key distinction |
|---|---|---|
| Cialis for ED as needed | Often 10 mg initially, adjusted to 5 mg or 20 mg | Use before anticipated sex under the prescribed frequency limit |
| Cialis for daily ED | Usually 2.5 mg, possibly 5 mg | Take consistently rather than adding a dose before each encounter |
| Cialis for BPH or ED/BPH | Commonly 5 mg daily | The clinician assesses urinary symptoms and interactions |
| Adcirca for PAH | Commonly 40 mg once daily as two 20 mg tablets | A PAH specialist directs treatment and any adjustments |
The PAH regimen does not establish 40 mg as an ED dose. A clinician may use lower amounts or avoid a regimen because of kidney or liver disease, interacting medicines, or other factors. Do not transfer a relative's instructions to your own prescription.
Standard instructions permit these tadalafil products with or without food. Formulation-specific directions still matter. A liquid PAH product or compounded preparation may require measuring, shaking, storage, or other steps that do not apply to a tablet.
Generic tadalafil and substitution
Tadalafil is the active-ingredient name, and approved generic products exist for relevant reference products. Ask the pharmacist which indication, strength, and instructions the prescription specifies. The word generic does not erase differences in the treatment plan.
An approved generic equivalent must meet quality and bioequivalence requirements. A lower price does not mean that the prescriber should increase the dose. Conversely, a compounded product with tadalafil does not automatically carry the same approval status as a conventional generic tablet.
Tell every prescriber about an existing tadalafil prescription. A person receiving PAH care may not recognize that an ED medicine duplicates the same drug. Reconciliation of the medicine list helps prevent accidental combination.
Similar adverse effects, different clinical contexts
Headache, flushing, indigestion, nasal congestion, back pain, muscle aches, and nausea can occur with tadalafil. Dose, the underlying disease, and other medicines influence the pattern. Someone with PAH may need a different assessment of new breathlessness or chest symptoms from someone taking occasional ED treatment.
Dizziness or fainting can reflect low blood pressure. Substantial alcohol may add to this effect. Discuss drinking with the treating team rather than applying a fixed safe number of drinks to every regimen.
An erection lasting more than four hours requires emergency care. Sudden vision or hearing loss also needs immediate medical attention. Chest pain, collapse, breathing difficulty, or a serious allergic reaction should prompt urgent assessment regardless of why the patient takes tadalafil.
Interactions both treatment teams need to know
Nitrates, including nitroglycerin, must not accompany tadalafil. Recreational poppers containing nitrites also create a dangerous interaction. Riociguat, another medicine used in some pulmonary hypertension settings, must not combine with tadalafil.
Sildenafil, including products used for PAH, and other PDE5 inhibitors can duplicate effects. A clinician needs to coordinate any change between therapies. Do not add an ED tablet because a specialist prescription carries a different name.
Ritonavir and other potent CYP3A4 inhibitors can increase tadalafil exposure. Rifampin and some enzyme-inducing drugs can reduce it. Alpha-blockers and other blood pressure medicines can add blood-pressure effects through another mechanism.
Report prescriptions, nonprescription medicines, supplements, and recreational substances to both teams. Include medicines used only occasionally and any treatment started by an urgent-care service. Shared information matters most when different clinicians prescribe for different conditions.
Getting the right prescription
A patient with ED can discuss Cialis or generic tadalafil with a primary care clinician, urologist, or appropriate telehealth clinician. PAH needs assessment and management from the relevant specialist rather than an ED questionnaire.
Ask the pharmacy to confirm the product, strength, quantity, schedule, and intended prescriber. Contact the care team if instructions unexpectedly change at refill. Keep the current medication list available so an additional prescription does not create duplicate tadalafil treatment.
Sources
- MedlinePlus: tadalafil. https://medlineplus.gov/druginfo/meds/a604008.html
- DailyMed: Cialis prescribing information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bcd8f8ab-81a2-4891-83db-24a0b0e25895
- Research and prescribing information. https://www.accessdata.fda.gov/apology_objects/abuse-detection-apology.html
- The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352681/
- Pulmonary Arterial Hypertension in Women. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935282/
Related reading
- Tadalafil and Cialis: uses and treatment choices
- Daily and as-needed tadalafil doses
- Tadalafil interactions
- Cialis and tadalafil side effects
- What to do when Cialis does not work
- Sildenafil treatment guide
- Erectile dysfunction treatment options
Medical Disclaimer: This content is provided for informational and educational purposes only and does not constitute personalized medical advice, diagnosis, or treatment. Always consult a qualified physician or licensed healthcare provider with any questions regarding a medical condition or prescription medication. Read our Editorial & Medical Review Policy.
